Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctioninterleukin-28 receptor binding

IFNL2 IFNL3

3.32e-053672GO:0032003
GeneOntologyMolecularFunctionryanodine-sensitive calcium-release channel activity

RYR1 RYR2

6.63e-054672GO:0005219
GeneOntologyMolecularFunctionligand-gated calcium channel activity

GRIN2C RYR1 RYR2

1.52e-0431673GO:0099604
GeneOntologyMolecularFunctioncalcium-induced calcium release activity

RYR1 RYR2

1.65e-046672GO:0048763
GeneOntologyBiologicalProcessskeletal muscle fiber development

CNTNAP1 SMO RYR1 MYORG

1.82e-0549664GO:0048741
GeneOntologyBiologicalProcessmyotube cell development

CNTNAP1 SMO RYR1 MYORG

2.68e-0554664GO:0014904
GeneOntologyBiologicalProcessvitamin D metabolic process

SNAI2 SNAI1 FGFR4

5.29e-0523663GO:0042359
GeneOntologyBiologicalProcessnegative regulation of vitamin D biosynthetic process

SNAI2 SNAI1

1.00e-045662GO:0010957
GeneOntologyCellularComponentinterleukin-28 receptor complex

IFNL2 IFNL3

9.46e-055652GO:0032002
GeneOntologyCellularComponentjunctional sarcoplasmic reticulum membrane

RYR1 RYR2

4.22e-0410652GO:0014701
DomainRyanrecept_TM4-6

RYR1 RYR2

3.68e-053662IPR009460
DomainRyR

RYR1 RYR2

3.68e-053662PF02026
DomainRyanodine_rcpt

RYR1 RYR2

3.68e-053662IPR003032
DomainRR_TM4-6

RYR1 RYR2

3.68e-053662PF06459
DomainRyan_recept

RYR1 RYR2

3.68e-053662IPR013333
DomainINF_lambda

IFNL2 IFNL3

7.35e-054662IPR029177
DomainIL28A

IFNL2 IFNL3

7.35e-054662PF15177
DomainSSX

SSX2 SSX3

1.83e-046662IPR028804
DomainRIH_assoc

RYR1 RYR2

1.83e-046662PF08454
DomainRIH_assoc-dom

RYR1 RYR2

1.83e-046662IPR013662
DomainRIH_dom

RYR1 RYR2

1.83e-046662IPR000699
DomainIns145_P3_rcpt

RYR1 RYR2

1.83e-046662IPR014821
DomainRyanodine_recept-rel

RYR1 RYR2

1.83e-046662IPR015925
Domain-

RYR1 RYR2

1.83e-0466621.25.10.30
DomainRYDR_ITPR

RYR1 RYR2

1.83e-046662PF01365
DomainIns145_P3_rec

RYR1 RYR2

1.83e-046662PF08709
DomainSSXRD

SSX2 SSX3

3.40e-048662PF09514
DomainSSXRD_motif

SSX2 SSX3

3.40e-048662IPR019041
DomainGalactose-bd-like

EPHB4 PTPRM CNTNAP1 PCSK4

3.42e-0494664IPR008979
DomainMIR

RYR1 RYR2

5.43e-0410662PS50919
DomainMIR

RYR1 RYR2

5.43e-0410662PF02815
DomainMIR

RYR1 RYR2

5.43e-0410662SM00472
DomainMIR_motif

RYR1 RYR2

5.43e-0410662IPR016093
DomainKRAB_RELATED

SSX2 SSX3

6.63e-0411662PS50806
DomainKrueppel-associated_box-rel

SSX2 SSX3

9.36e-0413662IPR003655
DomainEGF

SNED1 HSPG2 CNTNAP1 STAB1

1.03e-03126664PF00008
DomainConA-like_dom

HSPG2 PTPRM CNTNAP1 RYR1 RYR2

1.06e-03219665IPR013320
Domain-

EPHB4 CNTNAP1 PCSK4

2.20e-03736632.60.120.260
DomainGrowth_fac_rcpt_

EPHB4 HSPG2 PCSK4 STAB1

2.26e-03156664IPR009030
DomainEGF-like_CS

EPHB4 SNED1 HSPG2 CNTNAP1 STAB1

2.29e-03261665IPR013032
DomainEGF_2

EPHB4 SNED1 HSPG2 CNTNAP1 STAB1

2.45e-03265665PS01186
Domainfn3

EPHB4 SNED1 PTPRM IL27RA

2.59e-03162664PF00041
DomainWD40_repeat_dom

DCAF8 DCAF8L1 NUP37 TEP1 ARHGEF17

3.98e-03297665IPR017986
DomainFN3

EPHB4 SNED1 PTPRM IL27RA

4.16e-03185664SM00060
DomainPID

TBC1D1 SHC1

4.38e-0328662PF00640
DomainEGF_LAM_2

HSPG2 STAB1

5.02e-0330662PS50027
DomainEGF_LAM_1

HSPG2 STAB1

5.02e-0330662PS01248
DomainFN3

EPHB4 SNED1 PTPRM IL27RA

5.39e-03199664PS50853
DomainPID

TBC1D1 SHC1

5.70e-0332662PS01179
DomainFN3_dom

EPHB4 SNED1 PTPRM IL27RA

6.39e-03209664IPR003961
DomainEF-hand_8

RYR1 RYR2

6.41e-0334662PF13833
Domain-

DCAF8 DCAF8L1 NUP37 TEP1 ARHGEF17

6.43e-033336652.130.10.10
DomainWD40/YVTN_repeat-like_dom

DCAF8 DCAF8L1 NUP37 TEP1 ARHGEF17

6.59e-03335665IPR015943
DomainLaminin_EGF

HSPG2 STAB1

6.79e-0335662PF00053
DomainEGF_Lam

HSPG2 STAB1

6.79e-0335662SM00180
DomainLAM_G_DOMAIN

HSPG2 CNTNAP1

7.97e-0338662PS50025
DomainLaminin_EGF

HSPG2 STAB1

7.97e-0338662IPR002049
Domain-

EPHB4 SNED1 HSPG2 PTPRM FGFR4 TAPBP IL27RA

8.74e-036636672.60.40.10
DomainPTB

TBC1D1 SHC1

8.80e-0340662SM00462
DomainLaminin_G_2

HSPG2 CNTNAP1

8.80e-0340662PF02210
Pubmed

SOCS1, a novel interaction partner of p53 controlling oncogene-induced senescence.

SHC1 SOCS1 PCSK4

2.49e-07768320622265
Pubmed

Identification and analysis of two snail genes in the pufferfish (Fugu rubripes) and mapping of human SNA to 20q.

SNAI2 SNAI1

3.77e-06268210773451
Pubmed

Selective Interferon Responses of Intestinal Epithelial Cells Minimize Tumor Necrosis Factor Alpha Cytotoxicity.

IFNL2 IFNL3

3.77e-06268232847859
Pubmed

Tumor-induced upregulation of Twist, Snail, and Slug represses the activity of the human VE-cadherin promoter.

SNAI2 SNAI1

3.77e-06268219046938
Pubmed

Lambda interferon inhibits hepatitis B and C virus replication.

IFNL2 IFNL3

3.77e-06268215731279
Pubmed

Interleukin-28B dampens airway inflammation through up-regulation of natural killer cell-derived IFN-γ.

IFNL2 IFNL3

3.77e-06268228620197
Pubmed

Impact of Selected Signaling Proteins on SNAIL 1 and SNAIL 2 Expression in Ovarian Cancer Cell Lines in Relation to Cells' Cisplatin Resistance and EMT Markers Level.

SNAI2 SNAI1

3.77e-06268233478150
Pubmed

Antitumor activity of IFN-lambda in murine tumor models.

IFNL2 IFNL3

3.77e-06268216751416
Pubmed

Purification and characterization of recombinant human interleukin-29 expressed in Escherichia coli.

IFNL2 IFNL3

3.77e-06268216413080
Pubmed

Conserved and divergent roles for members of the Snail family of transcription factors in the chick and mouse embryo.

SNAI2 SNAI1

3.77e-0626829671584
Pubmed

SNAI1 and SNAI2 are asymmetrically expressed at the 2-cell stage and become segregated to the TE in the mouse blastocyst.

SNAI2 SNAI1

3.77e-06268220046880
Pubmed

Snail and Slug, key regulators of TGF-β-induced EMT, are sufficient for the induction of single-cell invasion.

SNAI2 SNAI1

3.77e-06268223618854
Pubmed

Interferon-λ mediates oral tolerance and inhibits antigen-specific, T-helper 2 cell-mediated inflammation in mouse intestine.

IFNL2 IFNL3

3.77e-06268221569774
Pubmed

Distinct EMT programs control normal mammary stem cells and tumour-initiating cells.

SNAI2 SNAI1

3.77e-06268226331542
Pubmed

Hepatic Snai1 and Snai2 promote liver regeneration and suppress liver fibrosis in mice.

SNAI2 SNAI1

3.77e-06268238451818
Pubmed

Interleukin 28A.rs12980602 and interleukin 28B.rs8103142 genotypes could be protective against HCV infection among Egyptians.

IFNL2 IFNL3

3.77e-06268230402710
Pubmed

Sequence analysis of the IL28A/IL28B inverted gene duplication that contains polymorphisms associated with treatment response in hepatitis C patients.

IFNL2 IFNL3

3.77e-06268222253847
Pubmed

Skeletal and cardiac ryanodine receptors exhibit different responses to Ca2+ overload and luminal ca2+.

RYR1 RYR2

3.77e-06268217259277
Pubmed

Expression and localization of transcription factors SNAIL and SLUG in mouse ovaries and pre-implantation embryos.

SNAI2 SNAI1

3.77e-06268225092544
Pubmed

'Snail factors in testicular germ cell tumours and their regulation by the BMP4 signalling pathway'.

SNAI2 SNAI1

3.77e-06268232441446
Pubmed

Assessment of serum interleukin-28 as a biomarker to predict mortality in traumatic patients with sepsis.

IFNL2 IFNL3

3.77e-06268235816926
Pubmed

Ryanodine receptor oligomeric interaction: identification of a putative binding region.

RYR1 RYR2

3.77e-06268214722100
Pubmed

The SNAI1 and SNAI2 proteins occupy their own and each other's promoter during chondrogenesis.

SNAI2 SNAI1

3.77e-06268223665016
Pubmed

Modularity and reshuffling of Snail and Slug expression during vertebrate evolution.

SNAI2 SNAI1

3.77e-06268212482931
Pubmed

Structural and functional interactions within ryanodine receptor.

RYR1 RYR2

3.77e-06268226009179
Pubmed

Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection.

IFNL2 IFNL3

3.77e-06268220235331
Pubmed

Murine Type III interferons are functionally redundant and correlate with bacterial burden during influenza/bacterial super-infection.

IFNL2 IFNL3

3.77e-06268234618816
Pubmed

Snail family transcription factors are implicated in thyroid carcinogenesis.

SNAI2 SNAI1

3.77e-06268217724139
Pubmed

Structure and Function of the Human Ryanodine Receptors and Their Association with Myopathies-Present State, Challenges, and Perspectives.

RYR1 RYR2

3.77e-06268232899693
Pubmed

IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease.

IFNL2 IFNL3

3.77e-06268221538995
Pubmed

IL-28B down-regulates regulatory T cells but does not improve the protective immunity following tuberculosis subunit vaccine immunization.

IFNL2 IFNL3

3.77e-06268226521300
Pubmed

Snai1 and Snai2 collaborate on tumor growth and metastasis properties of mouse skin carcinoma cell lines.

SNAI2 SNAI1

3.77e-06268218408755
Pubmed

SNAIL Transctiption factor in prostate cancer cells promotes neurite outgrowth.

SNAI2 SNAI1

3.77e-06268233132158
Pubmed

Recent advances in understanding the ryanodine receptor calcium release channels and their role in calcium signalling.

RYR1 RYR2

3.77e-06268230542613
Pubmed

Protective cellular and mucosal immune responses following nasal administration of a whole gamma-irradiated influenza A (subtype H1N1) vaccine adjuvanted with interleukin-28B in a mouse model.

IFNL2 IFNL3

3.77e-06268233409549
Pubmed

Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress.

SNAI2 SNAI1

3.77e-06268215314165
Pubmed

Ryanodine receptors are expressed and functionally active in mouse spermatogenic cells and their inhibition interferes with spermatogonial differentiation.

RYR1 RYR2

3.77e-06268215280431
Pubmed

IFN-λ3 is induced by Leishmania donovani and can inhibit parasite growth in cell line models but not in the mouse model, while it shows a significant association with leishmaniasis in humans.

IFNL2 IFNL3

3.77e-06268238193711
Pubmed

Expression of the ryanodine receptor isoforms in immune cells.

RYR1 RYR2

3.77e-06268211673493
Pubmed

B-lymphocytes from malignant hyperthermia-susceptible patients have an increased sensitivity to skeletal muscle ryanodine receptor activators.

RYR1 RYR2

3.77e-06268211673462
Pubmed

Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients.

IFNL2 IFNL3

3.77e-06268220576307
Pubmed

Slug and Snail have differential effects in directing colonic epithelial wound healing and partially mediate the restitutive effects of butyrate.

SNAI2 SNAI1

3.77e-06268231393789
Pubmed

Snail is an independent prognostic predictor for progression and patient survival of gastric cancer.

SNAI2 SNAI1

3.77e-06268222471696
Pubmed

TBC1Domain Family Member 25 deficiency aggravates cerebral ischemia-reperfusion injury via TAK1-JNK/p38 pathway.

TBC1D1 TBC1D25

3.77e-06268234837397
Pubmed

Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections.

IFNL2 IFNL3

3.77e-06268220335250
Pubmed

Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain.

RYR1 RYR2

3.77e-06268225370123
Pubmed

Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo.

IFNL2 IFNL3

3.77e-06268220739515
Pubmed

Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion.

RYR1 RYR2

3.77e-06268215033925
Pubmed

Snail2 cooperates with Snail1 in the repression of vitamin D receptor in colon cancer.

SNAI2 SNAI1

3.77e-06268219502595
Pubmed

[SNAI1 and SNAI2 - transcriptional master-regulators of epithelial-mesenchimal transition].

SNAI2 SNAI1

3.77e-06268226571812
Pubmed

The transcriptional repressor Snail promotes mammary tumor recurrence.

SNAI2 SNAI1

3.77e-06268216169465
Pubmed

Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels.

RYR1 RYR2

3.77e-06268218618700
Pubmed

Interferon-λ3 Promotes Epithelial Defense and Barrier Function Against Cryptosporidium parvum Infection.

IFNL2 IFNL3

3.77e-06268230849550
Pubmed

Expression of Snail and Slug in renal cell carcinoma: E-cadherin repressor Snail is associated with cancer invasion and prognosis.

SNAI2 SNAI1

3.77e-06268221808237
Pubmed

Interferon-λs: special immunomodulatory agents and potential therapeutic targets.

IFNL2 IFNL3

1.13e-05368223207147
Pubmed

Interferon lambda 2 promotes mammary tumor metastasis via angiogenesis extension and stimulation of cancer cell migration.

IFNL2 IFNL3

1.13e-05368229151074
Pubmed

Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.

RYR1 RYR2

1.13e-05368218403125
Pubmed

The transcription factors Snail and Slug activate the transforming growth factor-beta signaling pathway in breast cancer.

SNAI2 SNAI1

1.13e-05368222028892
Pubmed

Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model.

IFNL2 IFNL3

1.13e-05368215914836
Pubmed

Impact and regulation of lambda interferon response in human metapneumovirus infection.

IFNL2 IFNL3

1.13e-05368225355870
Pubmed

Full house: 12 receptors for 27 cytokines.

IFNL2 IFNL3

1.13e-05368215120645
Pubmed

Heterogeneous gene expression and functional activity of ryanodine receptors in resistance and conduit pulmonary as well as mesenteric artery smooth muscle cells.

RYR1 RYR2

1.13e-05368218434746
Pubmed

Gene polymorphisms of interleukin-28, p21-activated protein kinases 4, and response to interferon-α based therapy in Chinese patients with chronic hepatitis B.

IFNL2 IFNL3

1.13e-05368223652058
Pubmed

Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition.

SNAI2 SNAI1

1.13e-05368217018611
Pubmed

Immunohistochemical study of correlation between histologic subtype and expression of epithelial-mesenchymal transition-related proteins in synovial sarcomas.

SNAI2 SNAI1

1.13e-05368221809991
Pubmed

Helicobacter pylori-induced epithelial-mesenchymal transition, a potential role of gastric cancer initiation and an emergence of stem cells.

SNAI2 SNAI1

1.13e-05368225784376
Pubmed

SPRY domains in ryanodine receptors (Ca(2+)-release channels).

RYR1 RYR2

1.13e-0536829204703
Pubmed

The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues.

RYR1 RYR2

1.13e-0536827876312
Pubmed

Ryanodine receptors are expressed in epidermal keratinocytes and associated with keratinocyte differentiation and epidermal permeability barrier homeostasis.

RYR1 RYR2

1.13e-05368221881589
Pubmed

Dendritic differentiation of cerebellar Purkinje cells is promoted by ryanodine receptors expressed by Purkinje and granule cells.

RYR1 RYR2

1.13e-05368224123915
Pubmed

The snail superfamily of zinc-finger transcription factors.

SNAI2 SNAI1

1.13e-05368211994736
Pubmed

Snail family members unequally trigger EMT and thereby differ in their ability to promote the neoplastic transformation of mammary epithelial cells.

SNAI2 SNAI1

1.13e-05368224638100
Pubmed

Genetic polymorphisms of the IFNλ genes are associated with biochemical features in Han Chinese with HCV infection from Yunnan Province, China.

IFNL2 IFNL3

1.13e-05368224269996
Pubmed

Differential role of Snail1 and Snail2 zinc fingers in E-cadherin repression and epithelial to mesenchymal transition.

SNAI2 SNAI1

1.13e-05368224297167
Pubmed

Liposome-mediated IL-28 and IL-29 expression in A549 cells and anti-viral effect of IL-28 and IL-29 on WISH cells.

IFNL2 IFNL3

1.13e-05368216539846
Pubmed

HOPX hypermethylation promotes metastasis via activating SNAIL transcription in nasopharyngeal carcinoma.

SNAI2 SNAI1

1.13e-05368228146149
Pubmed

Proteomic Analysis of Epithelial to Mesenchymal Transition (EMT) Reveals Cross-talk between SNAIL and HDAC1 Proteins in Breast Cancer Cells.

SNAI2 SNAI1

1.13e-05368226764010
Pubmed

Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors).

RYR1 RYR2

1.13e-05368212213830
Pubmed

Dopamine D1 receptor signaling system regulates ryanodine receptor expression in ethanol physical dependence.

RYR1 RYR2

1.13e-05368223278119
Pubmed

Downregulation of miR-95 in gastric cancer promotes EMT via regulation of Slug, thereby promoting migration and invasion.

SNAI2 SNAI1

1.13e-05368230535480
Pubmed

Expression of the ryanodine receptor type 3 calcium release channel during development and differentiation of mammalian skeletal muscle cells.

RYR1 RYR2

1.13e-0536829242641
Pubmed

Type III interferon attenuates a vesicular stomatitis virus-based vaccine vector.

IFNL2 IFNL3

1.13e-05368225008938
Pubmed

Involvement of NK Cells in IL-28B-Mediated Immunity against Influenza Virus Infection.

IFNL2 IFNL3

1.13e-05368228637903
Pubmed

SSX2-4 expression in early-stage non-small cell lung cancer.

SSX2 SSX3

1.13e-05368224645645
Pubmed

The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression.

SNAI2 SNAI1

1.13e-05368210655586
Pubmed

Snail promotes lymph node metastasis and Twist enhances tumor deposit formation through epithelial-mesenchymal transition in colorectal cancer.

SNAI2 SNAI1

1.13e-05368222974478
Pubmed

Interleukin-28A enhances autoimmune disease in a retinal autoimmunity model.

IFNL2 IFNL3

1.13e-05368225138017
Pubmed

Bidirectional coupling between ryanodine receptors and Ca2+ release-activated Ca2+ (CRAC) channel machinery sustains store-operated Ca2+ entry in human T lymphocytes.

RYR1 RYR2

1.13e-05368222948152
Pubmed

Direct association of the reticulon protein RTN1A with the ryanodine receptor 2 in neurons.

RYR1 RYR2

1.13e-05368223454728
Pubmed

SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition.

SNAI2 SNAI1

1.13e-05368231165775
Pubmed

The transcription factors Slug (SNAI2) and Snail (SNAI1) regulate phospholipase D (PLD) promoter in opposite ways towards cancer cell invasion.

SNAI2 SNAI1

1.13e-05368226781944
Pubmed

Interferon-lambda serum levels in hepatitis C.

IFNL2 IFNL3

1.13e-05368221145813
Pubmed

Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain.

RYR1 RYR2

1.13e-05368210788707
Pubmed

Regulation of p63 isoforms by snail and slug transcription factors in human squamous cell carcinoma.

SNAI2 SNAI1

1.13e-05368220150431
Pubmed

The SLUG zinc-finger protein represses E-cadherin in breast cancer.

SNAI2 SNAI1

1.13e-05368211912130
Pubmed

CCL2 expression correlates with Snail expression and affects the prognosis of patients with gastric cancer.

SNAI2 SNAI1

1.13e-05368228215642
Pubmed

Induction of interferon lambda in influenza a virus infected cells treated with shRNAs against M1 transcript.

IFNL2 IFNL3

1.13e-05368226104331
Pubmed

Calcineurin upregulates local Ca(2+) signaling through ryanodine receptor-1 in airway smooth muscle cells.

RYR1 RYR2

1.13e-05368225239916
Pubmed

Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor.

RYR1 RYR2

1.13e-0536827621815
Pubmed

A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice.

RYR1 RYR2

1.13e-05368218643873
Cytoband19q13.13

IFNL2 IFNL3

2.24e-041568219q13.13
CytobandEnsembl 112 genes in cytogenetic band chrXp11

FAM120C TBC1D25 SSX2 SSX3 BMP15

2.48e-04377685chrXp11
GeneFamilyRyanodine receptors|Protein phosphatase 1 regulatory subunits

RYR1 RYR2

2.07e-053482287
GeneFamilyZinc fingers C2H2-type|SNAG transcriptional repressors

SNAI2 SNAI1

3.06e-04104821259
GeneFamilyFibronectin type III domain containing

EPHB4 SNED1 PTPRM IL27RA

8.49e-04160484555
GeneFamilyInterferons

IFNL2 IFNL3

3.25e-0332482598
ToppCellfrontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

HSPG2 TRH FAM180A SNAI1 GGT5

4.51e-0615968534c90711c5857cf6ada7b3acff99f1d48c7caf29
ToppCellfacs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KSR1 CLCA2 ARHGEF17 CSGALNACT1 STAB1

5.73e-06167685961e722442d786ab15d1e490941d2be265a9057a
ToppCellfacs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KSR1 CLCA2 ARHGEF17 CSGALNACT1 STAB1

5.73e-061676853760efc35d4e7e9c2da1a20f9795ddea397e2206
ToppCellPND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

EPHB4 CLCA2 GPR150 IL27RA STAB1

6.24e-0617068535e3945d8a540a3e2cec1b559316265aaad023d1
ToppCellPND01-Endothelial-Endothelial_lymphatic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

EPHB4 CLCA2 GPR150 IL27RA STAB1

6.24e-061706850ea625abaa25bab93b70b7000e8f90d5c0f9a0fb
ToppCellPND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

EPHB4 CLCA2 GPR150 IL27RA STAB1

6.24e-061706850b5ddc7d452db0a389927a367914f7d257703f7e
ToppCellfrontal_cortex-Non-neuronal-leptomeningeal_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

HSPG2 TRH FAM180A SNAI1 GGT5

6.42e-061716852e43fb129ee9bdc3b31febc43c10f959bf0f4a7d
ToppCellfrontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

HSPG2 TRH FAM180A SNAI1 GGT5

6.42e-06171685e219a1aa59a96e4bc3e2eacf985679174a51de41
ToppCellfacs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SNED1 CLCA2 GPR150 IFNL3 STAB1

8.69e-061826852cc434e46985c66fc36de05344a67aa96d90abc9
ToppCellfacs-Lung-24m-Endothelial-lymphatic_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SNED1 CLCA2 GPR150 IFNL3 STAB1

8.69e-061826850cde2775bdaaa2172499925bd59b0ac2d545eb27
ToppCellfacs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SNED1 CLCA2 GPR150 IFNL3 STAB1

8.69e-061826853e7457b2a70b45735fb75d6617b7f34cef28758e
ToppCellkidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

EPHB4 HSPG2 PTPRM STAB1 GGT5

1.15e-05193685daefbfd3a3dd1351fbe94b9abfd807db44d56c24
ToppCell3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SNED1 SNAI2 SNAI1 FGFR4 GGT5

1.21e-05195685bad7f2162000f29488b3c4b903dcac9a818621f7
ToppCellkidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

EPHB4 HSPG2 PTPRM STAB1 GGT5

1.31e-05198685259fbcc0f2ac281a3e4d693de45b986fe5e24841
ToppCellkidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

EPHB4 SNED1 HSPG2 SNAI2 STAB1

1.37e-05200685b1be27d134a8633e3e7862c6a0d7be2001d387f0
ToppCellSubstantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

SEC16B FAM180A SNAI1 BMP15

1.96e-0510468411d91471b6c4fa6b00a91d9fd4db72ee60d1f801
ToppCellSubstantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

SEC16B FAM180A SNAI1 BMP15

1.96e-05104684424a58b04c8b5108b70f15d8353c8e4b9db1e730
ToppCellSubstantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

SEC16B FAM180A SNAI1 BMP15

1.96e-051046849b05ae514437eb0c8b1b23607ae8cbc371ffa85b
ToppCellprimary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

HSPG2 TRH FAM180A GGT5

6.62e-05142684f4e4cde228149d5a536fbf0517ed71d81e296faf
ToppCellInfluenza_Severe-CD4+_T_naive|World / Disease group and Cell class

HSPG2 GPR150 TACR2 FGFR4

7.98e-05149684ce6552063510aa3e0b9d6e5b531eea67410e7056
ToppCellcritical-Epithelial-Basal|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CLCA2 SNAI2 RPS18 GGT5

9.30e-05155684cb6fbd36aa1fab29a1667ee13441bddc3d28846f
ToppCellInfluenza_Severe-CD4+_T_naive|Influenza_Severe / Disease group and Cell class

HSPG2 GPR150 TACR2 FGFR4

9.77e-05157684287bdc4e455cd0160261a93d13538e0def49fcd4
ToppCellsevere_influenza-CD4+_T_naive|World / disease group, cell group and cell class (v2)

HSPG2 CYP4F8 TACR2 FGFR4

1.00e-041586848ab3d8a9b7a1daa890d76dde1d6182af40b70021
ToppCellsevere_influenza-CD4+_T_naive|severe_influenza / disease group, cell group and cell class (v2)

HSPG2 CYP4F8 TACR2 FGFR4

1.00e-04158684ff3fa4bd06e01363429aec4bb587b95819bf0fc9
ToppCelltumor_Lymph_Node_/_Brain-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass

CA9 TRH RPS18 SNAI1

1.03e-04159684b3c52908cd24bbf851fac69db3850fc7f53c2092
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal|GW19 / Sample Type, Dataset, Time_group, and Cell type.

FADS3 FAM20B MMACHC IL27RA

1.03e-04159684f34f2729a3872fbb2939e76ad35d7e25f71b8f57
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal-Unfolded_protein_responsible_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type.

FADS3 FAM20B MMACHC IL27RA

1.03e-04159684929ed98f6c2ad14e8d5af5c6f11a5a3d4b388cf7
ToppCell343B-Lymphocytic-NK_cells-NK_cell_D3|343B / Donor, Lineage, Cell class and subclass (all cells)

DRAXIN SOCS1 SNAI1 GRIN2C

1.13e-041636848a4931c9fdaedcf6c319157821d3556cd25fc9e5
ToppCellPND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SNED1 CLCA2 GPR150 STAB1

1.16e-041646844cfc9f92e49f86d3639e018b35b6a60dc62f494a
ToppCellPND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SNED1 CLCA2 GPR150 STAB1

1.16e-041646847a8e5ef52a8fd2877d59ef0696af8a7af90bbed6
ToppCellPND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SNED1 CLCA2 GPR150 STAB1

1.16e-041646845e5bd81414ea2d64f73cdef19a0a78c17bec8c18
ToppCellPND10-Endothelial-Endothelial_lymphatic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SNED1 CLCA2 GPR150 STAB1

1.16e-04164684f13b8d9b7f42193f333d9a77571a1dde6bbb48d8
ToppCell356C-Fibroblasts-Fibroblast-D|356C / Donor, Lineage, Cell class and subclass (all cells)

TACR2 FGFR4 RYR2 GGT5

1.21e-041666847286a37b2827f3747469ffd0d76cbe81116db7ee
ToppCell356C-Fibroblasts-Fibroblast-D-|356C / Donor, Lineage, Cell class and subclass (all cells)

TACR2 FGFR4 RYR2 GGT5

1.21e-041666847c2eee0a4f45795a956acf936b85bdb35f1b1624
ToppCellPND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CA9 FAM180A TACR2 GRIN2C

1.24e-041676847abc785e688a384672d7fb5a62d32538fe7e5a51
ToppCellPND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CA9 FAM180A TACR2 GRIN2C

1.24e-04167684d50311b1f66f143bae4c4cf50e2e9b13c85d6920
ToppCell390C-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells)

SNAI1 MMACHC ZNF697 ZNF707

1.27e-041686848459d0a1bf6d4b5c83001097331f8b78fceb9305
ToppCellPND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

EPHB4 CLCA2 GPR150 STAB1

1.30e-04169684f077e39e41fffe7672541f5b72b80faaf56c597c
ToppCellP07-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

CA9 FAM180A TACR2 TAPBP

1.39e-041726849a256db817c1af1802203cc88a55d608fb328c63
ToppCellfacs-Large_Intestine-Distal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HSPG2 FAM180A SNAI2 RPS18

1.42e-04173684a5172dee859bf6c2eed46c48bd64dfef0ff9f28f
ToppCellfacs-Large_Intestine-Distal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HSPG2 FAM180A SNAI2 RPS18

1.42e-04173684639b5b0b33ce5aa0bc26363c059717012ddc14c0
ToppCellPND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CA9 FAM180A TACR2 GRIN2C

1.42e-04173684ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FADS3 PLCD1 SNAI1 GGT5

1.42e-041736842415b6ff49f334da570577d4e93484d024a3dbd5
ToppCelldroplet-Lung-LUNG-1m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRH PLEKHA8 STAB1 GGT5

1.42e-0417368426bba58f9fb215d1d155504906cd77e8774f6936
ToppCelldroplet-Lung-LUNG-1m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRH PLEKHA8 STAB1 GGT5

1.42e-0417368469b404e92aad3e6dff67e75466f073f20a71f13f
ToppCellPND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CA9 FAM180A TACR2 GRIN2C

1.42e-041736843725525b99a6011eda2ff5459b4fd2e1eab1f090
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FADS3 PLCD1 SNAI1 GGT5

1.42e-041736842acd0693a2dfe04e3c1b2125ea63efe92d13150b
ToppCelldroplet-Thymus-nan-21m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RPS18 TAPBP IL27RA GGT5

1.45e-04174684319bfafc66a21ad05ab35e0fd024c8b372a07165
ToppCellprimary_visual_cortex-Non-neuronal-leptomeningeal_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

HSPG2 TRH FAM180A SNAI1

1.45e-041746842891ab2fd05eb4bbd239d1a2865f21ef7f2df39e
ToppCellprimary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

HSPG2 TRH FAM180A SNAI1

1.45e-04174684eade55f86ef1f7a5355ad65cec3aa6bfc5d3c62d
ToppCelldroplet-Fat-Bat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SNED1 SEC16B FAM180A FAM20B

1.48e-04175684b4f01e7782cdd107d0817ef601891fd3a382bc35
ToppCelldroplet-Fat-Bat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SNED1 SEC16B FAM180A FAM20B

1.48e-04175684ef6f811d8e1839f405c3b41090ddf79be57a099f
ToppCelldroplet-Liver-LIVER-NPC-1m-Endothelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EPHB4 HSPG2 FADS3 SNAI1

1.48e-0417568498dc3b6f69a29d587f503898f09912700950e3d9
ToppCelldroplet-Fat-Bat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SNED1 SEC16B FAM180A FAM20B

1.48e-041756847f7598d46d10bff1cbea42f950bdde1aaa16e9a4
ToppCellfacs-Lung-Endomucin-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLCA2 GPR150 IFNL3 STAB1

1.52e-04176684057d2759fdc67176c25802b57a78064d8cc93205
ToppCellfacs-Lung-Endomucin-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLCA2 GPR150 IFNL3 STAB1

1.52e-04176684b81e5d23b31cefc8d374ef403e21acc390c14a80
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SNED1 SNAI2 USP43 CSGALNACT1

1.55e-04177684f30d757ee8db7e10d547498dab6560473c6ed7c0
ToppCellprimary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

HSPG2 TRH FAM180A SNAI1

1.55e-04177684599cf7f5b774e197a1b43c98e4b9a8c1a618f38a
ToppCellSevere-CD4+_T_activated|World / Disease group and Cell class

SEC16B SOCS1 RYR2 GGT5

1.58e-04178684ef6111238703579a34bd6948bd9d4ca6b7e16063
ToppCellE18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CA9 TRH FAM180A TACR2

1.58e-04178684bcbdd45a2307f8aea14122fa0144b96b1f6eec48
ToppCellE18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CA9 TRH FAM180A TACR2

1.58e-04178684c413861148129be1ee94f2ceb5999840217eebe5
ToppCellE16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SNED1 SNAI2 SOCS1 SNAI1

1.62e-04179684948c2a01ec7a626c68281e6e796a9f0527a88591
ToppCellfacs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FADS3 PTPRM SMO STAB1

1.65e-04180684baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c
ToppCellfacs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FADS3 PTPRM SMO STAB1

1.65e-041806842d608b9394d28d19cfc85c6ac94003d5177c8a92
ToppCellPCW_05-06-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

HSPG2 TRH CSGALNACT1 STAB1

1.65e-041806845861b44acfb8fe92c281c8355bf19c059b3dcd64
ToppCellP03-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

CA9 FAM180A TACR2 TAPBP

1.65e-041806842ccc77d769d3ffd77ab3af45e4f192785b6db79c
ToppCellfacs-Lung-24m-Endothelial-arterial_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FADS3 PTPRM SMO STAB1

1.65e-041806840f9b27054358c4737eed06c8ea01987cccc3cb55
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SNED1 SNAI2 USP43 CSGALNACT1

1.72e-04182684cc6f9d606a4f8717dc44928ceec2a257636043fd
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SNED1 SNAI2 USP43 CSGALNACT1

1.72e-0418268435b2a5625323bf0917214d3b82fafc4a8f5e75ff
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SNED1 SNAI2 USP43 CSGALNACT1

1.76e-0418368401ad18f198195ce341bae01a1c8c253cc4607766
ToppCelldroplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

HSPG2 FADS3 SMO ZNF697

1.76e-04183684351d575339038bd4a66f408da518c567444208e8
ToppCellE15.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

CA9 FAM180A TACR2 TAPBP

1.76e-04183684274f274cf60daa30d6a4cd603a3af7823bfb8016
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SNED1 HSPG2 CYP4F8 PTPRM

1.80e-04184684688428103e8b19f45f2f65d70a0f30c904c8411c
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SNED1 SNAI2 USP43 CSGALNACT1

1.80e-041846849a185e6ea86bbfbb48bfe88650a8c05ceba78d7f
ToppCelldroplet-Liver-HEPATOCYTES-1m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EPHB4 HSPG2 PLCD1 STAB1

1.83e-04185684742350093d90f96735dc73e3360cdd749bae63fd
ToppCell10x5'-GI_small-bowel-Myeloid_Dendritic-DC1|GI_small-bowel / Manually curated celltypes from each tissue

SMO PLCD1 ZNF697 GGT5

1.83e-0418568423ffba9216729b5bdb30b35742ba2627bb1200bf
ToppCelldroplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRAF4 CLCA2 AVPR2 ZNF697

1.91e-0418768422fd1959879705a8c1128faa9de66696c4e0b7e3
ToppCelldroplet-Heart-4Chambers-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FADS3 DRAXIN ARHGEF17 GGT5

1.91e-04187684dba4924d914a7dcd4901142684ba920c2404860b
ToppCelldroplet-Heart-4Chambers-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FADS3 DRAXIN ARHGEF17 GGT5

1.91e-041876849688141beef4f62613d7a810c5872ccb9afc1a71
ToppCelldroplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRAF4 CLCA2 AVPR2 ZNF697

1.91e-041876845fae538de481367cf6d9a2d52190d77b99f6922c
ToppCelldroplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRAF4 CLCA2 AVPR2 ZNF697

1.91e-041876840526c0a818cf28fd5b6ff65fe260e3c3a4a98a2a
ToppCellP28-Mesenchymal-developing_mesenchymal_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

TRAF4 TBC1D1 SNAI1 ARHGEF17

1.95e-04188684e7681efb4d2de7f1d8a89552fff76a829376bf1b
ToppCellfacs-Lung-3m-Endothelial-lymphatic_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

EPHB4 SNED1 CLCA2 STAB1

2.03e-04190684a1514d2186eb4fe569971ab22dc0c17d353fb94a
ToppCellfacs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

EPHB4 SNED1 CLCA2 STAB1

2.03e-041906840bb954a94317cfc742b9b6221bb80f8baa6d3ff1
ToppCellfacs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

EPHB4 SNED1 CLCA2 STAB1

2.03e-0419068426e2237f65cb43723c5da853831b40df2982d6e4
ToppCellPND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass

SNAI2 SNAI1 FGFR4 ARHGEF17

2.07e-04191684e7c605b56934d1383237c1f946dbccef25d91368
ToppCell3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HSPG2 PTPRM AVPR2 CSGALNACT1

2.07e-0419168404c7aa2e39fdd08ca24c10d43b29a5e41a73b9e0
ToppCell3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HSPG2 PTPRM AVPR2 CSGALNACT1

2.07e-04191684db8dd6bbba803585bdd6a55d5c403d383f2e9acf
ToppCell10x3'2.3-week_14-16-Endothelial-stroma-immature_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

EPHB4 HSPG2 PTPRM STAB1

2.11e-041926845af3b2b38495e925497c48f605d618bbf970965d
ToppCellfacs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EPHB4 HSPG2 CSGALNACT1 STAB1

2.11e-041926842bfac6b3956265205ca47d06888851ed68b65999
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

EPHB4 HSPG2 PTPRM STAB1

2.11e-0419268425cb6cc6cbf8dc20139d938adfc02ed7a8c3dfb6
ToppCell10x5'v1-week_17-19-Lymphocytic_B-B_lineage-naive_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

TRAF4 CNTNAP1 RPS18 TAPBP

2.11e-041926845d6569b0f879729aa89d4498c9c886ac9050be13
ToppCellHippocampus-Endothelial|Hippocampus / BrainAtlas - Mouse McCarroll V32

EPHB4 SHC1 SNAI1 GGT5

2.11e-0419268436deadab892d3e639a71f33697bb2d3cbbaa5372
ToppCellfacs-Liver-Non-hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EPHB4 HSPG2 CSGALNACT1 STAB1

2.11e-04192684d525f7f088a53110912600a7c9f6d33b9270d534
ToppCellTCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9

SNED1 PTPRM FAM180A CNTNAP1

2.16e-04193684194e7fa00a50cc4e026987b715323d125d79594e
ToppCellfacs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EPHB4 HSPG2 CSGALNACT1 STAB1

2.20e-04194684c8b9551b93a5aed62154b487db90130604a6125c
ToppCell15-Airway-Endothelial|Airway / Age, Tissue, Lineage and Cell class

HSPG2 TRH PTPRM AVPR2

2.20e-04194684ac0e48b0c09a7f57d30dff321b0c30a4c5e16ad9
ToppCell15-Airway-Endothelial-Endothelial|Airway / Age, Tissue, Lineage and Cell class

HSPG2 TRH PTPRM AVPR2

2.20e-04194684f3851337a2d17f4acef2cd812a766eb0b503748b
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

FADS3 FAM120C TBC1D25 ZNF707

2.20e-041946848f4b63b0b9a40765205e4ca6bd94a675a83dbe3d
ToppCellnormal_Lung-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass

TRAF4 RPS18 SMO PLCD1

2.20e-04194684d21461682fa755f588afe073abb6a777f339c4cc
DrugRifabutin [72559-06-9]; Down 200; 4.8uM; MCF7; HT_HG-U133A

TRAF4 LMF2 DCAF8 ZNF747 FGFR4 IL27RA

1.70e-051846764349_DN
DrugTrazodone hydrochloride [25332-39-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A

FADS3 FAM120C SNAI2 ZNF747 TEP1 CSGALNACT1

2.30e-051946767410_UP
DrugEtanidazole [22668-01-5]; Down 200; 18.6uM; MCF7; HT_HG-U133A

HSPG2 LMF2 FADS3 ZNF747 FGFR4 SSX3

2.30e-051946766072_DN
DrugPentoxifylline [6493-05-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A

CA9 LMF2 TEP1 ARHGEF17 RYR1 STAB1

2.36e-051956762290_UP
DrugFluvoxamine maleate [61718-82-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A

SNED1 HSPG2 KSR1 CYP4F8 PLCD1 ARHGEF17

2.43e-051966764114_UP
DrugAzathymine, 6 [932-53-6]; Up 200; 31.4uM; MCF7; HT_HG-U133A

SNED1 CYP4F8 LMF2 SOCS1 GRIN2C SSX3

2.43e-051966764106_UP
DrugAcacetin [480-44-4]; Down 200; 14uM; PC3; HT_HG-U133A

FADS3 ZNF747 PLCD1 POGZ RYR2 IL27RA

2.43e-051966763767_DN
Drug0316684-0000 [391209-55-5]; Up 200; 10uM; MCF7; HT_HG-U133A

HSPG2 TRAF4 LMF2 FAM120C PLCD1 POGZ

2.50e-051976767093_UP
DrugMethiazole; Down 200; 15uM; MCF7; HT_HG-U133A

HSPG2 TRAF4 FADS3 ZNF747 FGFR4 IL27RA

2.50e-051976764354_DN
DrugChelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A

KSR1 TRH PTPRM SNAI2 ZNF747 STAB1

2.50e-051976762779_UP
Drug2-hydroxycarbazole

RYR1 RYR2

2.55e-053672CID000093551
Drugcis-diammineplatinum(II

RYR1 RYR2

2.55e-053672CID000159790
Drug2-hydroxyheptanoic acid

RYR1 RYR2

2.55e-053672CID002750949
DrugRyanodyl 3-(pyridine-3-carboxylate

RYR1 RYR2

2.55e-053672CID005748312
Drug8N3-cADPR

RYR1 RYR2

2.55e-053672CID000127713
Drugaminodantrolene

RYR1 RYR2

2.55e-053672CID009570289
DrugSalsolinol hydrobromide [38221-21-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A

FADS3 SOCS1 PLCD1 FGFR4 ARHGEF17 RYR2

2.57e-051986762791_UP
DrugAminophylline [317-34-0]; Down 200; 9.6uM; HL60; HT_HG-U133A

EPHB4 KSR1 FADS3 FAM120C SSX3 CSGALNACT1

2.72e-052006763036_DN
DrugSulfabenzamide [127-71-9]; Up 200; 14.4uM; MCF7; HT_HG-U133A

CA9 KSR1 LMF2 ZNF747 PLCD1 SSX3

2.72e-052006762814_UP
Drugnifedipine

CYP4F8 FADS3 TRH TACR2 GRIN2C RYR1 RYR2 GGT5

2.90e-05415678CID000004485
Drugindo-1/AM

TRH RYR1 RYR2

3.12e-0521673CID000123918
DrugPCB74

RYR1 RYR2

5.10e-054672CID000036218
Drug148504-47-6

RYR1 RYR2

5.10e-054672CID006444275
DrugSC 38249

RYR1 RYR2

5.10e-054672CID000134834
DrugAC1L1U7A

RYR1 RYR2

5.10e-054672CID000035682
Drug2-imidazolidone-4-carboxylic acid

TRH GGT5

5.10e-054672CID000089477
Drug2-(4-nitrophenyl)benzoxazole

HSPG2 TACR2

8.48e-055672CID000070047
DrugA 68930

RYR1 RYR2

8.48e-055672ctd:C065380
DrugPalifermin

HSPG2 FGFR4

1.27e-046672DB00039
DrugMBED

RYR1 RYR2

1.27e-046672CID000129958
Drugchloro-m-cresol

RYR1 RYR2

1.27e-046672CID000012008
DrugAC1O528X

RYR1 RYR2

1.27e-046672CID006475857
DrugNSC114784

RYR1 RYR2

1.27e-046672CID000419425
DrugAC1L1JOO

SNAI2 SMO GGT5

1.49e-0435673CID000005137
DrugAzumoleno

RYR1 RYR2

1.77e-047672CID000056259
DrugBr2BAPTA

RYR1 RYR2

1.77e-047672CID003081001
Drug[[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate

RYR1 RYR2

1.77e-047672CID009547999
DrugGabexate mesilate [56974-61-9]; Up 200; 9.6uM; HL60; HT_HG-U133A

TRAF4 FADS3 ZNF747 CSGALNACT1 IL27RA

1.90e-041806752937_UP
DrugCamptothecine (S,+) [7689-03-4]; Up 200; 11.4uM; MCF7; HT_HG-U133A

HSPG2 LMF2 SNAI2 SOCS1 SNAI1

2.00e-041826752321_UP
DrugZuclopenthixol hydrochloride [633-59-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A

LMF2 SNAI2 PLCD1 TEP1 CSGALNACT1

2.05e-041836754843_UP
DrugAC1O3MDH

TACR2 GRIN2C RYR1 RYR2

2.34e-04102674CID006332158
Drugheptanal

CA9 B3GALT4

2.36e-048672ctd:C046204
DrugApigenin [520-36-5]; Up 200; 14.8uM; MCF7; HT_HG-U133A

TRAF4 PLCD1 FGFR4 RYR2 BMP15

2.44e-041906753257_UP
DrugFluticasone propionate [80474-14-2]; Down 200; 8uM; MCF7; HT_HG-U133A

CLCA2 ZNF747 PLCD1 RYR2 BMP15

2.62e-041936754129_DN
DrugSpiramycin [8025-81-8]; Down 200; 4.8uM; MCF7; HT_HG-U133A

LMF2 FAM120C ZNF747 ARHGEF17 BMP15

2.68e-041946753938_DN
DrugSkimmianine [83-95-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A

HSPG2 FADS3 FGFR4 TEP1 SSX3

2.68e-041946756066_DN
Drugtrifluoperazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A

TRH AVPR2 CNTNAP1 FGFR4 STAB1

2.75e-041956756183_UP
DrugXylazine [7361-61-7]; Up 200; 18.2uM; HL60; HT_HG-U133A

CNTNAP1 SOCS1 RYR1 RYR2 IL27RA

2.75e-041956752132_UP
DrugApomorphine hydrochloride hemihydrate [41372-20-7]; Up 200; 6.4uM; PC3; HG-U133A

CA9 ZNF747 SMO PLCD1 FGFR4

2.81e-041966751923_UP
DrugEthambutol dihydrochloride [1070-11-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A

CA9 SOCS1 PLCD1 GRIN2C BMP15

2.81e-041966751481_UP
DrugAminocaproic acid [60-32-2]; Up 200; 30.4uM; HL60; HT_HG-U133A

EPHB4 HSPG2 FADS3 FAM120C CNTNAP1

2.81e-041966753122_UP
DrugBaclofen (R,S) [1134-47-0]; Up 200; 18.8uM; HL60; HG-U133A

EPHB4 SMO PLCD1 BMP15 STAB1

2.81e-041966752036_UP
DrugHydrochlorothiazide [58-93-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A

LMF2 FADS3 SOCS1 FGFR4 IL27RA

2.81e-041966751487_DN
DrugNiridazole [61-57-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A

LMF2 FADS3 ZNF747 TEP1 RYR2

2.88e-041976753301_DN
Drugchlorpromazine hydrochloride; Up 200; 1uM; PC3; HT_HG-U133A

TRAF4 FADS3 FGFR4 CSGALNACT1 RYR1

2.88e-041976751217_UP
DrugMethoxamine hydrochloride [61-16-5]; Up 200; 16.2uM; HL60; HT_HG-U133A

KSR1 CLCA2 CNTNAP1 RYR1 STAB1

2.88e-041976752488_UP
DrugU-62066 [87151-85-7]; Down 200; 1uM; PC3; HT_HG-U133A

HSPG2 FAM120C ZNF747 FGFR4 IL27RA

2.88e-041976754553_DN
DrugArticaine hydrochloride [23964-57-0]; Up 200; 12.4uM; HL60; HT_HG-U133A

EPHB4 PTPRM SNAI2 IL27RA STAB1

2.88e-041976753138_UP
DrugAdrenosterone [382-45-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A

LMF2 PTPRM FAM120C FGFR4 RYR2

2.95e-041986755464_UP
DrugFurosemide [54-31-9]; Up 200; 12uM; MCF7; HT_HG-U133A

CA9 LMF2 GRIN2C RYR1 RYR2

2.95e-041986753197_UP
DrugTrapidil [15421-84-8]; Up 200; 19.4uM; HL60; HT_HG-U133A

EPHB4 CNTNAP1 PLCD1 RYR2 IL27RA

2.95e-041986753136_UP
DrugBromopride [4093-35-0]; Up 200; 11.6uM; PC3; HT_HG-U133A

ZNF747 SMO ARHGEF17 RYR1 STAB1

2.95e-041986754278_UP
Drug0175029-0000 [211245-78-2]; Up 200; 10uM; PC3; HT_HG-U133A

SNAI1 FGFR4 RYR1 IL27RA STAB1

2.95e-041986753691_UP
DrugSR-95639A [115767-94-7]; Up 200; 10uM; MCF7; HT_HG-U133A

LMF2 ZNF747 TEP1 ARHGEF17 SSX3

2.95e-041986754977_UP
Druggenistein; Down 200; 1uM; MCF7; HG-U133A

SNED1 LMF2 ZNF747 SMO PLCD1

3.02e-04199675267_DN
DrugCeftazidime pentahydrate [78439-06-2]; Down 200; 6.2uM; MCF7; HT_HG-U133A

TBC1D1 SNAI2 ZNF747 POGZ IL27RA

3.02e-041996755473_DN
DrugZoxazolamine [61-80-3]; Up 200; 23.8uM; HL60; HT_HG-U133A

ZNF671 LMF2 DCAF8 IL27RA BMP15

3.02e-041996751270_UP
DrugClopamide [636-54-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A

EPHB4 SNED1 TRH ZNF747 PLCD1

3.02e-041996753220_UP
DrugTerazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A

HSPG2 LMF2 FADS3 ZNF747 SSX3

3.02e-041996756092_DN
DrugNorcyclobenzaprine [303-50-4]; Up 200; 15.4uM; HL60; HT_HG-U133A

CA9 TRAF4 FADS3 RYR1 IL27RA

3.02e-041996752469_UP
DrugNatamycin [7681-93-8]; Down 200; 6uM; PC3; HT_HG-U133A

LMF2 FADS3 DCAF8 PLCD1 IL27RA

3.02e-041996755809_DN
DrugCotinine (-) [486-56-6]; Up 200; 22.6uM; MCF7; HT_HG-U133A

CA9 HSPG2 FAM120C ARHGEF17 RYR2

3.02e-041996751511_UP
DrugNalidixic acid sodium salt hydrate; Up 200; 14.6uM; MCF7; HT_HG-U133A

CA9 CLCA2 FGFR4 TEP1 BMP15

3.02e-041996752297_UP
DrugAdenosine 5'-monophosphate monohydrate [18422-05-4]; Up 200; 11uM; MCF7; HT_HG-U133A

LMF2 TBC1D1 SNAI2 SOCS1 IL27RA

3.02e-041996755359_UP
DrugAtropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; MCF7; HT_HG-U133A

DCAF8 FGFR4 TEP1 RYR2 IL27RA

3.02e-041996757219_DN
Drugantazoline

TRH GRIN2C

3.03e-049672CID000002200
DrugCGS 22652

AVPR2 TBC1D1

3.03e-049672CID000131717
Drugd(CH2)5-Davp

AVPR2 SNAI1

3.03e-049672CID000123750
DrugMcp-tva-argipressin

TRH AVPR2

3.03e-049672CID000122322
DrugFosfosal [6064-83-1]; Up 200; 18.4uM; HL60; HT_HG-U133A

HSPG2 PTPRM ZNF747 SOCS1 RYR1

3.09e-042006752997_UP
DrugCondelphine [7633-69-4]; Up 200; 8.8uM; MCF7; HT_HG-U133A

CNTNAP1 PLCD1 CSGALNACT1 RYR1 BMP15

3.09e-042006753538_UP
DrugTobramycin [32986-56-4]; Up 200; 8.6uM; HL60; HT_HG-U133A

CA9 KSR1 CLCA2 IL27RA STAB1

3.09e-042006752481_UP
Drugrosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A

TRAF4 SNAI2 ZNF747 RYR2 BMP15

3.09e-042006755230_DN
DrugAmidopyrine [58-15-1]; Up 200; 17.2uM; PC3; HT_HG-U133A

HSPG2 ZNF671 SMO ARHGEF17 STAB1

3.09e-042006754481_UP
DrugLypressin

TRH AVPR2 PLCD1

3.60e-0447673CID000005772
Diseasecongenital myopathy 1A (implicated_via_orthology)

RYR1 RYR2

1.52e-053672DOID:3529 (implicated_via_orthology)
Diseasemalignant hyperthermia (implicated_via_orthology)

RYR1 RYR2

1.52e-053672DOID:8545 (implicated_via_orthology)
Diseaserheumatic heart disease (biomarker_via_orthology)

SOCS1 SNAI1

3.30e-0412672DOID:0050827 (biomarker_via_orthology)
DiseaseTachyarrhythmia

TRH RYR2

7.59e-0418672C0080203
DiseaseTachycardia

TRH RYR2

7.59e-0418672C0039231

Protein segments in the cluster

PeptideGeneStartEntry
RFARLHGISGWSPRI

CNTNAP1

51

P78357
IGFRLLHSPQHWRPR

LINC00588

41

Q9Y4M8
RTPVRGLFHLWHEKR

CSGALNACT1

466

Q8TDX6
VVGVPARWHRGRLSS

C9orf163

31

Q8N9P6
RIGGIRLRHQHWSLV

FGFR4

196

P22455
HWRVNPSRTPGGRHR

B3GALT4

231

O96024
RALQLHLHWGAAGRP

CA9

221

Q16790
RQVPRGEVFRPHRWH

NOXA1

176

Q86UR1
RLNWGHIPSHPRVTV

HSPG2

441

P98160
QVTWHKRGGSLPVRH

HSPG2

2371

P98160
DQHRKPRGWSFGIRH

ODF3B

226

A8MYP8
RAQRPADGLHSWHIF

ARHGEF17

206

Q96PE2
HWLRTGWVPRRGAVH

EPHB4

71

P54760
GFHHARTTIPKWLQR

KIAA1109

4956

Q2LD37
LTNVARPHRGTWHIQ

BMP15

101

O95972
RPHRGTWHIQILGFP

BMP15

106

O95972
RGVVQQSLTPHWGHR

PCSK4

76

Q6UW60
RVHRGRWHGEVAIRL

KSR1

626

Q8IVT5
RHHRRWREPGVGATD

DCAF8

556

Q5TAQ9
VFIRRKHWHRGLGTA

FAM169B

81

Q8N8A8
AWGEVPRHQLRGHLT

IL27RA

436

Q6UWB1
LRQHHGWVVRGVFAL

PLEKHA8

441

Q96JA3
LRTFHHGVRVDGIAW

NUP37

66

Q8NFH4
HPRFGGWFAIRGVVL

MMACHC

151

Q9Y4U1
RHNVGHLSRIYPAGW

PLCD1

541

P51178
GPALWTPQASHHRRR

DRAXIN

46

Q8NBI3
GDKWRHHRRLLTPAF

CYP4F8

141

P98187
WPGGRILHRHELDTF

FAM120C

776

Q9NX05
TAGPRTRGRLHHWLY

IFNL2

146

Q8IZJ0
PTAGPRTRGRLHHWL

IFNL3

141

Q8IZI9
HRRHGRLPWAQLFQP

GGT5

151

P36269
HRWSRAVLFPAAHRP

FAM180A

21

Q6UWF9
FVRHLLQRAHQPGWR

DCAF8L1

551

A6NGE4
WAQRHPGGSRLIGHH

FADS3

51

Q9Y5Q0
HRGQRWHLGSEPFGR

RYR1

1126

P21817
GSHIRWGQPFRLRHV

RYR2

286

Q92736
IIARAWSSGGPRFHH

PKD1L1

141

Q8TDX9
GLTLWRRAVPGHQAH

TACR2

221

P21452
REIRQFHFTGWPDHG

PTPRM

1051

P28827
FIRWLLKLGHHGRAP

TOR2A

196

Q8N2E6
GFGGHRGWPVRQRHM

TBC1D25

456

Q3MII6
PGTHGRLWTGAHRLF

LMF2

426

Q9BU23
LPRGLTWIAHSRHGQ

POGZ

846

Q7Z3K3
GPRGHQALYRQRWPH

GPR150

386

Q8NGU9
RPWLLQGHIRTHTGE

SNAI2

196

O43623
GPKRGEHAWTHRLRE

SSX3

156

Q99909
GRDFRIHNFRSHPWL

VHLL

86

Q6RSH7
WGPLSVHGAHERLRA

SOCS1

81

O15524
GADRRWHQGGHHPRV

SNED1

1201

Q8TER0
GSRGRVFVHEWAHLR

CLCA2

156

Q9UQC9
RWPKGFSIHRRLHLT

ZNF707

326

Q96C28
RPWLLQGHVRTHTGE

SNAI1

191

O95863
HWAVDRVLHLRRPGG

USP43

481

Q70EL4
RPNLIRHWKVHTGER

ZNF671

491

Q8TAW3
FRHPPSQVTRLWGRH

nan

126

Q8N2B8
PHRISLHGIDLRWGV

TEP1

931

Q99973
WREGARLAAFPAHHG

TEP1

1871

Q99973
GPKRGEHAWTHRLRE

SSX2

156

Q16385
PFGLEWRRQHLGKGH

TAPBP

201

O15533
LQKHRHPWGRTYREG

FAM20B

231

O75063
AKHQWVHRPGGEGRR

ZNF747

281

Q9BV97
AVGQGVPRHHRGEIW

TBC1D1

796

Q86TI0
GHRNSLLGPAHWIVF

STAB1

1206

Q9NY15
RWSGPLRHLQGHLNT

TRAF4

91

Q9BUZ4
KIRAHRGLRHFWGLR

RPS18

116

P62269
RGLRHFWGLRVRGQH

RPS18

121

P62269
VAWAHGRRQGLGPIH

SMO

756

Q99835
GFRRDGHHRPVPHSW

SEC16B

26

Q96JE7
GRHTQRPFWTFRVSH

nan

131

Q8IYB0
LPWRRHLSLGSRHRG

ZNF697

141

Q5TEC3
QHKRQHPGRRSPWLA

TRH

131

P20396
RNIPGFWVTAFRHHP

TSPYL6

246

Q8N831
LWRRLHGRPGHASAL

STARD7

61

Q9NQZ5
RHGSFVNKPTRGWLH

SHC1

136

P29353
ALARRGRRGHWAPIH

AVPR2

61

P30518
THPKARDWFQGHLRR

MYORG

436

Q6NSJ0
LLHAAWARGSRPRHA

GRIN2C

1066

Q14957